INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Lobbying registrant
CR

CHECKMATE GOVERNMENT RELATIONS

Open in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections15with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • Lobbied forevidence
    CAPRICOR THERAPEUTICS, INC.LDA RR 2026 third quarter · Health issues · Sep 3, 2026
  • Lobbied forevidence
    ELI LILLY & CoLDA Q2 2026 second quarter · Health issues, Trade · Aug 26, 2026
  • Lobbied forevidence
    AbbVie Inc.LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    RAYONIER ADVANCED MATERIALS INC.LDA Q2 2026 second quarter · TAR, Trade · Aug 26, 2026
  • Lobbied forevidence
    Biohaven Ltd.LDA Q1 2026 first quarter · MED, Pharmacy, Health issues · Aug 26, 2026
  • Lobbied forevidence
    GEO GROUP INCLDA 1A 2026 first quarter · Homeland security, LAW · Aug 26, 2026
  • Lobbied forevidence
    PHIBRO ANIMAL HEALTH CORPLDA Q1 2026 first quarter · ANI, Science/technology · Aug 26, 2026
  • Lobbied forevidence
    T1 Energy Inc.LDA Q1 2026 first quarter · Energy, MAN, Taxation · Aug 26, 2026
  • Lobbied forevidence
    REGENERON PHARMACEUTICALS, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    GSK plcLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
  • Lobbied forevidence
    Salesforce, Inc.LDA Q2 2026 second quarter · Computer industry, Government issues · Aug 26, 2026
  • Lobbied forevidence
    Neuronetics, Inc.LDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • Lobbied forevidence
    INCYTE CORPLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    PYXUS INTERNATIONAL, INC.LDA 2T 2026 second quarter · TOB, Agriculture, Trade · Aug 26, 2026
  • Lobbied forevidence
    SILVER BOW MINING CORP.LDA Q1 2026 first quarter · NAT · Aug 26, 2026